Clinical trialUNITERAREApr 9
Researchers are testing a new medicine called difelikefalin to see if it's safe and works well for teenagers on kidney dialysis who have severe itching. Itching is a common problem for dialysis patients that can really affect their quality of life. This study will check whether the medicine helps reduce itching and what side effects it might cause.
WHY IT MATTERSThis is the first trial testing difelikefalin specifically in adolescents on hemodialysis with moderate-to-severe pruritus — a condition that significantly impacts quality of life but has limited treatment options for younger patients.
Clinical trialUNITERAREApr 3
Researchers are testing a new drug called Xaluritamig to treat Ewing sarcoma, a rare bone cancer that has come back or stopped responding to previous treatments. This is an early-stage study (Phase 1) that will include children, teenagers, and adults. The study is now accepting patients and is expected to start in April 2026.
WHY IT MATTERSThis trial offers a potential new treatment option for patients with relapsed or refractory Ewing sarcoma, a rare pediatric cancer with limited treatment alternatives after standard therapies fail.
ResearchPUBMEDApr 1
Researchers in Brazil studied dental care for children and teens with rare diseases at five specialized centers. They found that over 1,000 young patients with 244 different rare diseases received dental treatment, with blood-related diseases being the most common. On average, kids didn't see a dentist for the first time until age 8, and many had to travel far from home to get specialized dental care.
WHY IT MATTERSThis study shows that children with rare diseases often wait years before receiving dental care and face significant travel barriers—highlighting a critical gap in specialized dental services that families should advocate for in their own communities.